Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Firefly Neuroscience Inc AIFF

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches... see more

Recent & Breaking News (NDAQ:AIFF)

    Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA(TM) Technology with Zeto's FDA-Cleared EEG Device Platform

    GlobeNewswire 7 days ago

    Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors

    GlobeNewswire 12 days ago

    Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

    GlobeNewswire August 26, 2024

    Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

    GlobeNewswire August 22, 2024

    Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

    GlobeNewswire August 21, 2024

    UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

    GlobeNewswire August 13, 2024

    Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

    GlobeNewswire August 13, 2024